Overview

Effect of Melatonin on Feeding Intolerance and Incidence of Necrotizing Enterocolitis in Preterm Infants

Status:
Completed
Trial end date:
2019-12-31
Target enrollment:
0
Participant gender:
All
Summary
Assesses the efficacy of melatonin in treatment of feeding intolerance in preterm infants, the time needed to reach full enteral intake, the incidence of necrotizing enterocolitis and measures the level of tumor necrosis factor-alpha as a marker of oxidative stress.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Ain Shams University
Treatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Melatonin
Criteria
Inclusion Criteria:

- Preterm infants (<37 weeks of gestation)

- Evidence of feeding intolerance

Exclusion Criteria:

- Infants with hypoxic ischemic encephalopathy

- Infants on nothing per os

- Infants with high oxygen needs wither on invasive or non-invasive mechanical
ventilation

- Major congenital anomalies

- Intracranial hemorrhage

- Respiratory distress syndrome